APA (7th ed.) Citation

S, J., G, G., VCA, M., M, T., V, J., S, S., . . . W, S. (2020). An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions. Clinical pharmacokinetics, 59(3), 349. https://doi.org/10.1007/s40262-019-00819-4

Chicago Style (17th ed.) Citation

S, Joshi, et al. "An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions." Clinical Pharmacokinetics 59, no. 3 (2020): 349. https://doi.org/10.1007/s40262-019-00819-4.

MLA (9th ed.) Citation

S, Joshi, et al. "An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions." Clinical Pharmacokinetics, vol. 59, no. 3, 2020, p. 349, https://doi.org/10.1007/s40262-019-00819-4.